Altium Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-475,000	Closed	-$2.63M	–	61
2024 Q4	$2.63M	Buy	475,000 +145,000	+44%	+$803K	0.75%	41
2024 Q3	$2.75M	Buy	+330,000	New	+$2.75M	0.81%	40
2023 Q1	–	Sell	-70,000	Closed	-$713K	–	107
2022 Q4	$713K	Buy	+70,000	New	+$713K	0.36%	49